Recent studies have revealed that an enhancement of sodium-proton exchange is a frequently observed ion transport abnormality in essential hypertension. An altered antiport activity not only is measurable in blood cells of hypertensive subjects ex vivo but also is detectable in skeletal muscle in vivo. Several lines of argument suggest that the altered antiport activity is not an epiphenomenon of hypertension: 1) the increased activity is found only in a subgroup of patients with high blood pressure, 2) it is not tightly correlated to the severity or duration of hypertension, and 3) high sodium-proton exchange activity persists over time and is not affected by antihypertensive treatment. Available evidence suggests that enhanced sodium-proton exchange is associated with or a cause for the structural alterations found in resistance vessels of hypertensive individuals (media hypertrophy) and left ventricular hypertrophy. This review summarizes some of the physiological properties and roles of the sodium-proton exchanger and discusses its kinetic properties in essential hypertension. Furthermore, the reasons for the enhanced antiport activity and its potential implications regarding the pathogenesis of hypertension are discussed.
I n spite of substantial research efforts, the etiology and pathogenesis of human essential hypertension remain unclear. In 1952, the first evidence was presented that the Na + content in arterial tissue is elevated in essential hypertension. 1 Subsequently, many investigators have described raised intracellular Na + contents mainly in peripheral blood cells in both experimental and clinical hypertension, 2 -6 although unchanged and reduced intracellular Na + has been reported as well. 7 This has raised the possibility that a generalized membrane transport abnormality responsible for the differences in intracellular cation content may play a crucial role in the genesis of hypertension. In spite of the wide acceptance of this concept, it remains a matter of controversy which membrane function is primarily abnormal and whether altered membrane transport is due to extracellular factors or represents an intrinsic abnormality. In the red cell, an elevated Na + -Li + countertransport rate is probably the best reproducible finding among the Na + transport systems in primary hypertension. 5 It remains controversial whether this transport system is a special mode of function of the ubiquitous Na + -H + antiport. 8 - 11 Recent investigations have consequently focused on Na + -H + exchange, an ion transport mechanism involved in several important cellular functions. The purpose of the present review is to critically evaluate the available data and to discuss the potential role of an abnormal Na + -H + exchange in the pathogenesis of primary hypertension.
Basic Properties of the Na + -H + Exchanger
The Na + -H + exchanger is an integral membrane protein found in all eukaryotic cells. Driven by the inwardly directed Na + gradient established by the Na + / K + -ATPase, the Na + -H + exchanger promotes an electroneutral 1:1 exchange of intracellular H + for extracellular Na + . In many cells, the transport is activated by an increase in the cytosolic proton concentration in an allosteric mode; i.e., protons are not only transported but also control a regulatory site within the protein. 12 This is reflected by Hill coefficients (n) of > 1 when the dependence of Na + -H + exchange activity on pHj is analyzed. In other tissues, e.g., rat parotid acinar cells, no such cooperativity was found. 13 It appears reasonable that different isoforms of the Na + -H + exchanger (see below) also display different "pH r sensing" properties. Besides Na + as the physiological substrate, the Na + -H + exchanger also accepts Li + and NH^. Another major characteristic of the antiport is its susceptibility to inhibition by amiloride and its N-substituted analogues.
14 " 18 From binding studies, the number of Na + -H + exchanger sites was estimated at 500 per human platelet 19 and 2,000 per rat thymocyte.
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Molecular Biology of the Na + -H + Exchanger
The Na + -H + exchanger has been cloned by genetic complementation of mutants lacking Na + -H + exchange activity with human genomic DNA.tion of the exchanger on serine residues. 22 - 23 The protein is N-glycosylated on two sites. Immunological studies have led to an estimate of 110 kd for the molecular weight of the glycosylated transporter. The protein seems to be expressed in all cell types. 24 In polarized epithelia, e.g., in the kidney and the small intestine, its localization is confined to the basolateral membrane. 2526 The gene encoding for NHE-1 is located on the short arm of chromosome 1,27-29 a n ( j j t s structure, including intron-exon organization, has recently been determined. 30 The sequences of rabbit, rat, and pig NHE-1 have been established as well, and the homology of these clones to the human NHE-1 is remarkably high.25,26,31,32 Besides NHE-1, there is evidence for the existence of a second isoform of the Na + -H + exchanger, referred to as 33 This latter antiport is assumed to be expressed on the apical (luminal) membrane of polarized epithelia where its proposed role involves the transcellular transport of Na + , Cl", and HCO 3 ". The sequence encoding for NHE- 2 has not yet been published, and its characterization is still based on kinetic and pharmacological studies. One major feature of NHE-2 is its reduced susceptibility to inhibition by amiloride. 33 Recently, two more putative isoforms of the Na + -H + exchanger have been obtained by homology cloning from rat and rabbit tissues, and these isoforms are addressed as NHE-3 and NHE-4, respectively. The messenger RNA encoding for NHE-3 is highly expressed in colon, small intestine, and kidney cortex, and NHE-4 is predominantly found in the stomach.
31
- 34 Expression studies of NHE-4 have to be awaited to ensure that this gene actually encodes for a protein that mediates Na + -H + exchange. Furthermore, the functional implications of the differences in amino acid composition of these latter antiports remain to be investigated.
Hence, the use of the term "Na + -H + exchanger" for all transporters that mediate amiloride-sensitive, Na + -dependent pHj control and Na + absorption is not precise. Most kinetic studies of Na + -H + exchange in human hypertension have been conducted on blood cells. For leukocytes, the expression of NHE-1 has been proved by reverse transcription polymerase chain reaction.
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Northern blot analysis has shown expression of NHE-1 in rat vascular smooth muscle cells 36 and in human skeletal muscle. 24 The amiloride sensitivity of the Na + -H + exchanger activity determined in most hypertension studies may be taken as circumstantial evidence that the relatively amiloride-insensitive isoform NHE-2 was not involved (although detectable amounts of NHE-2 message were reported to be expressed also in adrenal gland and skeletal muscle; see Reference 34). Whether any of the other hitherto known isoforms (NHE-3, NHE-4) are expressed in blood cells, vascular smooth muscle cells, or skeletal muscle is unknown at present. It should be emphasized here that we cannot decide at present which member or members of the NHE "family" account for the enhanced Na + -H + exchange activity in essential hypertension.
Physiological Roles of the Na + -H + Antiport
There are three major events in which Na + -H + exchange is involved: 1) pH; regulation in unstimulated cells, 2) cell volume control, and 3) stimulus-response coupling and cell proliferation.
i Control in Unstimulated Cells
If pH; falls below a set point, Na
+ -H + exchange is activated and extrudes intracellular H + for extracellular Na + until the pH, of the set point is reached again. In this context, the term set point refers to the steady-state pH, above which the Na + -H + exchanger is not active.
14 The importance of a delicate pH, regulation for cell metabolism is underlined by the fact that the Na + -H + exchanger is supported by additional pH r regulating transport systems, e.g., H + -ATPases as well as Na + -dependent and Na + -independent HCO 3~-Cl~ exchangers.
18 -37 '
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Cell Volume Control NHE-1 is also involved in the regulatory volume increase after an osmotically induced cell shrinkage. The activation of the Na + -H + exchanger results in Na + uptake and alkalinization of the cytosol with a subsequent activation of the HCO 3 "-C1" exchanger. The resulting net uptake of NaCl and osmotically obliged water finally restores the original cell volume.
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Role in Stimulus-Response Coupling and Cell Proliferation
One of the earliest events after stimulation of cells by, for example, hormones or growth factors is a rise in pHj. This is caused by phosphorylation of the Na + -H + exchanger, which shifts its set point to more alkaline pHj values. This event has two important consequences: 1) the Na + -H + exchanger extrudes protons until pHj reaches a new, more alkaline steady state, and 2) the activation curve of the antiport is completely shifted to a more alkaline range. Thus, even a mild cytosolic acidification to, for example, pH 7.1 is now met with distinctly faster recovery rates.
14 The first and generally accepted understanding of this phenomenon argues that cell stimulation induces a whole subset of proton-generating reactions, e.g., the hydrolysis of energy-rich phosphates and enhanced glycolysis. An early activation of the Na + -H + exchanger during cell stimulation anticipates the need for an effective H + removal and underlines the "housekeeping" function of the antiport. However, there is some evidence for a second functional importance of the early enhancement of Na + -H + exchange, which is related to stimulus-response coupling.
Ample reports exist proposing an involvement of the platelet Na + -H + exchanger in activation of phospholipase A 2 , 41 the release of thromboxane B 2 , 42 and glycolysis. 43 In smooth muscle cells, which are more directly related to the pathogenesis of hypertension, blockade of Na + -H + exchange was reported to curtail the generation of 1,2-diacylglycerol, i.e., the mediator of protein kinase C activation. 44 in a positive feedback loop, as depicted in Figure 1 . However, this concept is not generally accepted.
-
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It can be concluded that the antiport-mediated alkalinization is not a "second messenger" per se but may constitute a permissive factor in stimulus-response coupling.
Because activation by growth factors is one of the major characteristics of the Na + -H + exchanger in proliferating cells, numerous investigations have aimed at elucidating its potential role in cell replication (for review, see Reference 15). In essential hypertension, vascular smooth muscle cell hypertrophy, hyperplasia, or both may represent an important pathophysiological step in the manifestation and progression of raised arterial blood pressure.
375 '-58 It is interesting to speculate whether an abnormal behavior of the Na + -H + exchanger participates in vascular smooth muscle growth in hypertension.
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It has been reported that blockade of Na + -H + exchange impairs cell proliferation, and cells lacking NHE-1 do not grow at slightly acidic pH. However, these cells resume growth when supplemented with HCO 3~, which raises pH;.
60
-61 Again, as already discussed above for signal transduction, these results can be taken to underline the basic "housekeeping" functions of NHE-1 that are improved by its activation. On the other hand, some evidence suggests that a more alkaline pHi is permissive for cell growth, as seen from an enhancement of protein synthesis. 62 The transcription of NHE-1 is dramatically enhanced in cells after stimulation with growth or differentiation factors and peaks early during the cell cycle, 63 -64 which might be considered an additional argument for a role of Na + -H + exchange in cell proliferation.
In conclusion, Na + -H + exchange is not likely to be an initiator of cell proliferation but may, similar to its role in stimulus-response coupling, constitute a permissive factor.
Pitfalls and Open Questions
Lacking more specific alternatives, we so far have only two means to assess the potential involvement of Na + -H + exchange activity in cellular signal transduction and cell proliferation, i.e., inhibition of this ion transport by amiloride or its analogues or comparison of cellular responses in Na + -containing and Na + -free media. However, pharmacological inhibition by amiloride is hampered by the fact that this class of substances is not sufficiently specific, as amiloride and its analogues not only prevent activation of Na + -H + exchange but, at higher concentrations, also affect Na + -Ca 2+ exchange and protein kinase C, to name but two. 15 Likewise, the removal of extracellular Na + not only inhibits Na + -H + exchange but also lowers [Na + ]j and inhibits a variety of Na + -dependent transporters.
Although it is generally known that the main buffer system in vivo is the CO 2 /HCO 3~ system, most studies with respect to Na + -H + exchange and pHj regulation have been conducted in nominally HCO 3~-free media, as experimental setups containing HCO 3~ require great efforts to control pH, temperature, and gassing conditions. In renal mesangial cells 38 and fibroblasts, 65 it was found that pHj is distinctly higher in the presence than in the absence of HCO 3 ". Furthermore, with HCO 3 " available, cell stimulation did not evoke any significant rise in pH,. This prompted the opinion that recordings on agonist-induced alkalinization are of minor if any physiological significance. However, this generalization appears largely unjustified. We and others 66 -67 have shown that the antiport-mediated, thrombin-induced alkalinization in human platelets occurs in both the absence and presence of HCO 3 ". Likewise, stimulation of Na + -H + exchange evokes a rise in pHj in macrophages 68 and T cells 69 in the presence of HCO 3 ". For vascular smooth muscle cells, it has been shown that growth factors lead to an increase in pH ; in the presence of HCO 3 " that persists for as long as 24 hours. 70 It appears that different cell types may be equipped with different pHj-regulating systems and, hence, also activate and/or express different ion transport systems on stimulation. Therefore, any final statement regarding the existence and physiological relevance of agonist-induced antiport-mediated pHj rises appears premature.
Modulation of Na + -H + Exchange Activity In Vivo
A variety of hormones, e.g., insulin, testosterone, and vitamin D, may alter Na + -H + exchange activity in vivo (for review, see References 71-73). Yet most of the animal studies have been performed on kidney membrane preparations. Therefore, it is difficult to distinguish which of the antiport isoforms was influenced.
In humans, long-term nephropathy has been reported to be associated with an enhanced lymphocyte Na + -H + exchange activity, and this may be caused by the longterm metabolic acidosis in these patients. 74 Metabolic acidosis has been demonstrated to result in an increased expression of the gene encoding for NHE-1 in rat renal cortex 75 and in cell cultures of renal origin. 76 Excessive NaCl intake in humans (>300 mmol/day) also enhances 31 P-NMR, phosphorus-31 nuclear magnetic resonance spectroscopy. All values are means; the numbers of individuals enrolled are given in parentheses. Units are those used in original publications. "Enhancement" refers to factor by which V max is accelerated in hypertensive patients.
the activity of the antiport in lymphocytes by a hitherto unknown mechanism. 77 High cholesterol, on the other hand, was shown to inhibit Na + -H + exchange in human lymphoblasts in vitro, 78 which might be related to alterations in membrane fluidity.
In conclusion, numerous questions concerning the in vivo regulation of Na + -H + exchange activity remain to be answered. 
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The Findings in Essential Hypertension
Although hypertension is manifested in resistance vessels, most examinations of Na + -H + exchange (with few exceptions) have been conducted on blood cells of normotensive and hypertensive subjects ex vivo assuming that the measured abnormalities represent equivalent defects in the vascular bed in vivo.
Studies on Blood Cells Using a Swelling Assay
Using a swelling assay, Livne et al 86 were the first to demonstrate an accelerated Na + -H + exchange in platelets of hypertensive subjects, and this finding was confirmed by others.
87 " 89 However, the major disadvantages of this technique are that an exact kinetic analysis of Na + -H + exchange activity cannot be attained and that the connection between Na + -H + exchange and swelling is rather circumstantial.
Measurements of Na + -H + Exchange by Standard Techniques
Here we discuss the potential alterations in Na + -H + exchange activity in essential hypertension when determined by more straightforward techniques, i.e., pHj measurements by fluorescent dyes and measurements of pHj-dependent Na + fluxes. An overview is given in Table 1 .
All reports except one agree with respect to the finding that Na + -H + exchange is significantly enhanced in blood cells of hypertensive individuals ex vivo. Furthermore, one study shows an enhanced pH| recovery in skeletal muscle in vivo using a nuclear magnetic resonance technique. 94 All studies imply that an enhanced Na + -H + exchange cannot be regarded as a general abnormality affecting all patients with essential hypertension; a considerable number of the hypertensive patients display Na + -H + exchange activities not different from normotensive subjects. This raises the question of whether the usual way of looking at data from normotensive and hypertensive individuals by comparing mean values is appropriate.
As shown in ever, in contrast to numerous other variables that were found to be altered in essential hypertension, e.g., elevated cytosolic free Ca 2+ , Na + -H + exchange activity is correlated neither to the severity of hypertension, i.e., to the actual elevation of systolic, diastolic, or mean arterial blood pressure, nor to its duration. Although only marginal information is available regarding the effect of antihypertensive treatment on Na + -H + exchange activity, accessible data seem to indicate that Na + -H + exchange activity is maintained during antihypertensive treatment despite a significant reduction in blood pressure. 97 Furthermore, although there is evidence for in vivo modulation of Na + -H + exchange activity (see above), there is no noticeable change in individual Na + -H + exchange activity values within several months. 868997 Thus, the broad overlap of Na + -H + exchange activities in normotensive and hypertensive individuals as well as its distinct elevation in some hypertensive patients could lead to the alternative view that two different subgroups in hypertension are characterized by either "high" or "low" antiport activity. This hypothesis is supported by recent findings of Canessa et al, 80 who described a bimodal distribution of red blood cell antiport activity in hypertensive patients. We have also tried to divide hypertensive patients into two subgroups with respect to their platelet antiport activity. By comparison of the V max values of both groups, we calculated an enhancement factor of 2.4 in unstimulated and one of 1.8 in thrombin-stimulated platelets.
97 Figure 2 illustrates these findings. Resting pH| was not different in normotension and hypertension, but on stimulation with 0.1 unit/mL thrombin, the platelets of hypertensive patients displayed a significantly faster and larger pHj rise (for details, see Figure  2 legend).
The existence of two subgroups could also explain the differences in the enhancement factors of Na + -H + exchange reported in the various studies (Table 1) just by the different number of hypertensive individuals included with either "low" or "high" antiport activity. This concept is in agreement with the notion that primary hypertension is a polygenetic disease. It suggests the existence of several subgroups of essential hypertensive patients, which may be defined by their respective genetic background and characterized by alterations in specific intermediate phenotypes. However, the investigation of larger groups of patients has to be awaited until this hypothesis can be generally accepted.
Enhanced Na + -H + Exchange and pH,
One crucial yet unresolved problem is whether acceleration of Na + -H + exchange is associated with intracellular alkalinization. As outlined above, cell activation induces phosphorylation of the antiport, thereby enhancing V max and shifting the set point to more alkaline values. Hence, if an enhanced Na + -H + exchange in hypertension is paralleled by alkalinization, one may speculate that the enhanced activity is caused by an enhanced phosphorylation of the protein. On the other hand, unchanged pH; may suggest an enhancement of the activity by other mechanisms, e.g., expression of more exchanger units per cell.
Available reports on pHj in different cells and tissues in normotension and hypertension are summarized in Table 2 . Resnick et al 101 found a significantly lower pH ( in red blood cells of hypertensive compared with normotensive individuals. In contrast, studies on leukocytes have indicated an alkaline shift of pH, in hypertension. However, in some of these studies, 9294 pH; values of >7.4 were reported, which seem to lie beyond the physiological range. The reasons for this remain obscure. In platelets, on the other hand, most investigators agree that pH ; is unchanged in essential hypertension.
Two investigations appear of special interest, as they were conducted under more physiological conditions. Dudley et al 94 detected identical pH; values in normotensive and hypertensive individuals in resting skeletal muscle in vivo, although pHi recovery on maximal exercise was faster in hypertensive than in normotensive individuals. Likewise, by measuring pHj in human resistance arteries in the presence of HCO 3 ", Izzard et al 104 found no differences in this parameter in resistance vessels from normotensive and hypertensive individuals. Despite higher Na + -H + exchange rates, the majority of reports do not report any significant alkalinization in the cells of hypertensive patients ex vivo.
Changes in the Kinetic Parameters of the Na
+ -H + Exchanger in Essential Hypertension Besides baseline pH f , two additional kinetic parameters of the Na + -H + exchanger have been investigated so far. Some groups determined K m for extracellular Na + and pHoj (or K m for internal H + ), i.e., the pH at which half-maximal activation of the Na + -H + exchanger occurs. As shown in Table 3 , all reports agree with respect to the fact that neither K m nor pHo. 5 groups. Canessa's group, 80 on the other hand, demonstrated distinctly reduced Hill coefficients in red blood cells of hypertensive patients compared with normotensive control subjects.
Potential Reasons for Enhanced Na + -H + Exchange Activity in Essential Hypertension
Na
+ -H + Exchange as a Mirror of Systemic Alterations?
Although the activity of the Na + -H + exchanger may be enhanced by various hormones or by marked alterations in acid-base or NaCl metabolism in vivo, the existence of such general disturbances in essential hypertension has never been established. Furthermore, it appears unlikely that hormones could lead to a simultaneous alteration of Na + -H + exchange in all blood cells despite their different receptor specificities and signaltransducing pathways. ]j must be elevated to the range of 0.5-1 /AM until an activation of the antiport is visible. 112 Role of protein kinase C. Because protein kinase C enhances the activity of Na + -H + exchange, the question arises whether protein kinase C activity is increased in essential hypertension, thereby establishing a more extensively phosphorylated and more "active" antiport. This, however, should result in a more alkaline set point, an increased pH i; and, potentially, a changed Hill coefficient, whereas an increased V max is not necessarily expected. Most of the findings in the literature seem to argue against any of these above-listed changes (Tables  2-4 , but see Reference 99). Furthermore, no evidence has yet been provided that protein kinase C activity is actually altered in essential hypertension.
Cellular Reasons for Enhanced
Role of plasma lipids. As Na + -Li + countertransport seems to be accelerated in individuals with an abnormal plasma lipid composition 113 -116 and keeping in mind the similarities between Na + -Li + countertransport and Na + -H + exchange, one might wonder whether plasma lipid abnormalities could account for the enhanced Na + -H + exchange in hypertension. In vitro studies on immortalized lymphoblasts revealed that artificially increasing membrane cholesterol decreased antiport activity and basal pH;. 117 The authors suggested that alterations in the fatty acid composition of the plasma membrane can dramatically affect the activity of ion transport systems. On the other hand, inhibitors (simvastatin, pravastatin) of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase) decreased Na + -H + exchange activity and pH, in lymphoblasts. Because in these experiments membrane cholesterol was not depleted, the authors suggested that the effects of these inhibitors resulted from an impaired glycosylation of newly synthesized Na + -H + exchanger protein.
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In the study by Goldsmith et al 95 on leukocyte Na + -H + exchange activity, the hypertensive patients displayed higher serum cholesterol levels than the normotensive controls. The authors found a significant negative correlation between serum cholesterol levels and pHi in cells from hypertensive patients but not in cells from normotensive controls.
95 Na + -H + exchange was positively correlated to serum triglyceride levels, again only in the hypertensive population, however. Weder et al 120 compared the effect of placebo versus an HMG CoA reductase inhibitor (lovastatin) in hypercholesterolemic patients on red blood cell cation transport and on platelet Na + -H + exchange (as determined by a swelling assay). Lovastatin significantly reduced plasma total and low density lipoprotein cholesterol and raised high density lipoprotein cholesterol levels. Whereas red blood cell Na + -Li + countertransport and Na + -K + -Cl" cotransport remained unaffected by this treatment, platelet Na + -H + exchange was significantly reduced in lovastatin-but not in placebo-treated patients.
Taken together, these data show that differences in plasma lipid composition may affect the membrane fluidity, thereby also changing the activity of membrane transport systems such as Na + -H + exchange. Whether such a mechanism can partially or fully account for the enhancement of Na + -H + exchange in essential hypertension remains to be demonstrated.
Involvement of genetic factors. Lifton et al
28 previously demonstrated a polymorphism in the NHE-1 gene that was found in an intron, i.e., a noncoding region of the DNA. Therefore, this polymorphism is unlikely to be of physiological or pathophysiological significance. Likewise, Dudley et al 121 detected a silent polymorphism in the coding region of the gene that occurs at a frequency of 41% and results from a single base pair substitution (C-*T at nucleotide 69; Reference 34). Genetic linkage analysis by both groups has yielded no evidence for NHE-1 to be a candidate gene in hypertension.
121 ' 122 In one approach, both groups used Na + -Li + countertransport activity (instead of Na + -H + exchange activity) as the quantitative trait. Both groups agreed with respect to the conclusion that mutations at the NHE-1 gene locus are not responsible for the observed variations in Na + -Li + countertransport. Using hypertension as a discrete trait, Lifton et al 122 also reported that NHE-1 alleles segregated randomly among sibling pairs, which may provide further evidence against the NHE-1 gene as a candidate gene for hypertension.
No data are available regarding the kinetic properties and the regulation of the recently cloned isoforms NHE-3 and NHE-4.
>
34 It remains unknown whether one of these isoforms mediates Na + -Li + countertransport, whether there is coexpression in some tissues, and whether one of these isoforms might be a candidate gene for hypertension.
The presently available data on the kinetics of the "hypertensive" Na + -H + exchanger would also be compatible with an isolated increase in V max , which might be indicative of an increased number of transporters. Recently, the messenger RNA encoding for NHE-1 was detected in human lymphocytes and neutrophils by reverse transcription polymerase chain reaction. 35 This should allow the establishment of a polymerase chain reaction-based assay for the quantification of Na + -H + exchanger messenger RNA in normotensive and hypertensive individuals. It must be stated that at present there is no indication of a genetic abnormality in the Na + -H + exchanger that would explain its enhancement in essential hypertension. 104 on human resistance arteries, in which pH ; was identical in noncontracting smooth muscle cells from normotensive and hypertensive individuals but significantly more alkaline in norepinephrine-stimulated specimens of hypertensive patients. Although circumstantial, a comparable conclusion may be drawn from the in vivo study of Dudley et al. 94 Although identical in resting skeletal muscle, p H appeared to be somewhat more alkaline in hypertensive patients compared with normotensive controls during and at the end of an isotonic exercise.
Potential Involvement of the
94
Na
+ -H + Exchange and Renal Na + Absorption
One of the first theories relating Na + -H + exchange to the pathogenesis of hypertension relates to its role in renal Na + absorption. 123 It was proposed that an enhanced Na + -H + exchange could augment tubular Na + absorption and might therefore constitute the frequently proposed defect in Na + excretion that could cause hypertension. Our present knowledge does not strengthen this earlier notion, because all changes in Na + -H + antiport activity hitherto reported refer to the isoform NHE-1, which obviously is not involved in epithelial Na + transport.
Enhanced Stimulus-Response Coupling
If one accepts the concept that antiport-mediated alkalinization provides a permissive factor in cell stimulus-response coupling, a more active Na + -H + exchanger in hypertensive patients could enhance the vasoconstricting effect of circulating hormones despite a quantitatively unchanged hormonal output. It appears worthwhile to investigate whether individuals with an enhanced Na + -H + exchange also display an augmented blood pressure response on infusion of vasoconstricting stimuli.
Enhanced Cell Proliferation
Hypertension is commonly associated with distinct structural alterations in the vasculature, commonly referred to as media hypertrophy/hyperplasia. 51 -53 Cross sections from peripheral resistance vessels reveal a decreased lumen/wall ratio in hypertensive compared with normotensive individuals. These vascular structural changes as well as left ventricular hypertrophy 124 were regarded to be of an adaptive nature only, i.e., a result of the increased pressure load. Subsequent findings have challenged this concept. It has been suggested that pressure-independent factors contribute to growth in vascular smooth muscle cells as well as in cardiomyocytes. 515356125 Thus, smooth muscle cells from the spontaneously hypertensive rat in culture display a distinctly faster replication (at least in early passages) compared with normotensive controls from the Wistar-Kyoto strain. 59 This enhanced growth is paralleled by an enhanced activity of the Na + -H + exchanger in spontaneously hypertensive rats.
Only recently, Strazzullo et al 96 described a significant correlation between the enhancement of Na + -H + exchange in lymphocytes of hypertensive patients and left ventricular hypertrophy. Again, this points to a link between high Na + -H + exchange and abnormal cell growth.
At present, the causality between high Na + -H + exchange and increased cell proliferation remains unclear. Cell stimulation by growth factors or phorbol ester induces an early increased transcription of NHE-1.
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Hence, an enhanced activity of the Na + -H + exchanger could simply reflect the appropriate response to an increased growth tendency. However, the enhancement of Na + -H + exchange activity also exists in nonproliferating cells, e.g., red blood cells and platelets. Thus, an alternative concept can be proposed in which an increased activity of the antiport constitutes a permissive factor for cell proliferation (see above). Further clarification of the relation between antiport activity and cell growth appears of utmost importance for the understanding of the potential role of this ion transport system in the pathogenesis of essential hypertension.
General Conclusions and Perspectives
Evidence is accumulating that Na + -H + exchange is enhanced in all blood cells and tissues of a subgroup of patients with essential hypertension, although the exact percentage of individuals afflicted has not yet been quantified. Preliminary data suggest that this ion transport abnormality neither reflects the actual increase in blood pressure nor regresses on blood pressure normalization. It may thus be concluded that elevated Na + -H + exchange is not an epiphenomenon of hypertension and may be related to the pathogenesis of this disease. The enhancement of antiport activity could be one factor that promotes an enhanced cell growth and thus could participate in media hypertrophy/hyperplasia and left ventricular hypertrophy in essential hypertension. Future studies should aim at forming two different groups of essential hypertensive patients depending on their antiport characteristics. This should enable us not only to determine the kinetic abnormalities of the transport more precisely but also to investigate whether these subgroups differ distinctly in other physiological or clinical parameters. Finally, it should not be overlooked that an enhancement of Na + -H + exchange is also frequently found in insulin-dependent diabetes mellitus (for review, see Reference 126), and it has been reasoned that this transport abnormality could participate in the development of diabetic nephropathy and left ventricular hypertrophy. 127 Future studies therefore should also consider whether altered Na + -H + exchange might constitute the yet missing link between diabetes and hypertension and the structural organ changes found in these disorders. 
